We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00413114
Recruitment Status : Completed
First Posted : December 19, 2006
Last Update Posted : August 26, 2013
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Gemin X )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2009
  Study Completion Date : November 2009
  Certification or Request for Extension to Delay Results Submission: August 16, 2013